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Abstract
Background: While the presence of the chitinase-like molecule YKL40 has been reported in COPD and asthma, its
relevance to inflammatory processes elicited by cigarette smoke and common environmental allergens, such as
house dust mite (HDM), is not well understood. The objective of the current study was to assess expression and
function of BRP-39, the murine equivalent of YKL40 in a murine model of cigarette smoke-induced inflammation
and contrast expression and function to a model of HDM-induced allergic airway inflammation.
Methods: CD1, C57BL/6, and BALB/c mice were room air- or cigarette smoke-exposed for 4 days in a whole-body
exposure system. In separate experiments, BALB/c mice were challenged with HDM extract once a day for 10 days.
BRP-39 was assessed by ELISA and immunohistochemistry. IL-13, IL-1R1, IL-18, and BRP-39 knock out (KO) mice
were utilized to assess the mechanism and relevance of BRP-39 in cigarette smoke- and HDM-induced airway
inflammation.
Results: Cigarette smoke exposure elicited a robust induction of BRP-39 but not the catalytically active chitinase,
AMCase, in lung epithelial cells and alveolar macrophages of all mouse strains tested. Both BRP-39 and AMCase
were increased in lung tissue after HDM exposure. Examining smoke-exposed IL-1R1, IL-18, and IL-13 deficient
mice, BRP-39 induction was found to be IL-1 and not IL-18 or IL-13 dependent, while induction of BRP-39 by HDM
was independent of IL-1 and IL-13. Despite the importance of BRP-39 in cellular inflammation in HDM-induced
airway inflammation, BRP-39 was found to be redundant for cigarette smoke-induced airway inflammation and the
adjuvant properties of cigarette smoke.
Conclusions: These data highlight the contrast between the importance of BRP-39 in HDM- and cigarette smoke-
induced inflammation. While functionally important in HDM-induced inflammation, BRP-39 is a biomarker of
cigarette smoke induced inflammation which is the byproduct of an IL-1 inflammatory pathway.
Background
Chronic obstructive pulmonary disease (COPD) is a
leading cause of morbidity and mortality worldwide
[1,2]. COPD is characterized as airflow limitation that is
not fully reversible, progressive in nature, and associated
with an abnormal inflammatory response in the lung to
noxious particles or gases such as those contained
within cigarette smoke [3]. The cellular components of
this inflammatory response are characteristically macro-
phages, neutrophils, and CD8+ T lymphocytes [4-9].
A number of mediators released by these cells likely
play a critical role in airflow obstruction because of
their potential to induce mucus hypersecretion and
alveolar destruction. Although recent studies have impli-
cated members of the IL-1 family of cytokines in the
inflammatory pathways activated by cigarette smoke
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cellular and molecular mechanisms of cigarette smoke
induced inflammation will shed light on disease patho-
genesis and identify future therapeutic targets.
It is well understood that family-18 glycosyl hydrolases
such as the chitinase-like molecule YKL-40 and the
murine homologue breast regression protein (BRP)-39
are upregulated in a variety of inflammatory conditions
[12-14]. Two members of this family of enzymatically
active and inactive chitinases, acidic mammalian chiti-
nase (AMCase) and BRP-39 have been shown to be cru-
cial in murine models of allergic inflammation.
Specifically, BRP-39 and AMCase have been shown to
be a requirement for allergic sensitization in ovalbumin
(OVA) and house dust mite (HDM) models of allergic
airways disease [15,16]. Additionally, YKL-40 was found
to be significantly elevated in smokers without COPD
and further elevated in smokers with diagnosed COPD
[17,18]. Moreover, human macrophages stimulated with
YKL-40 produced the neutrophil chemoattractant IL-8,
providing evidence that chitinases such as BRP-39 may
contribute to the inflammatory response elicited by
cigarette smoke. Studies in animal models, however, are
needed to investigate the functional relevance and
mechanism of induction of chitinases in distinct pul-
monary inflammatory diseases. In murine models, cigar-
ette smoke causes neutrophil infiltration into the lungs
similar to smoke-induced inflammation in humans
[19-22]. Thus, murine models may be utilized to investi-
gate the importance of BRP-39 in cigarette smoke-
induced inflammatory processes relative to the already
established importance of BRP-39 in models of allergic
airway disease.
In this study we sought to determine the relevance of
BRP-39, in the inflammatory response elicited by cigar-
ette smoke and house dust mite. We identify BRP-39 as
a biomarker, but not a mediator, of subacute cigarette
smoke-induced inflammation and identify IL-1R1
mediated pathways as critical for the induction of BRP-
39. In contrast, BRP-39 was required for the expression
of allergic airway inflammation. Our study shows a dif-
ferential requirement for BRP-39 in cigarette smoke-
induced inflammation and models of allergic asthma.
Methods
Animals
Female inbred C57BL/6, BALB/c mice and outbred CD1
mice (6-8 wk old) were purchased from Charles River
Laboratories (Montreal, PQ, Canada). BRP-39 deficient
mice, developed on a BALB/c background, and their
wild type (WT) littermates were bred at Medimmune
LLC, Gaithersburg, MD, USA. IL-13 deficient mice on a
BALB/c background (kindly provided by A McKenzie,
MRC lab, Cambridge England [23]) were bred at
McMaster University. IL-1R1 knock out (KO) and IL-18
KO mice on a C57BL/6 background were obtained from
The Jackson Laboratories (Bar Harbour ME, USA). All
mice were maintained under specific pathogen-free con-
ditions in an access-restricted area, on a 12-h light-dark
cycle, with food and water provided ad libitum.T h e
Animal Research Ethics Board of McMaster University
approved all experiments.
Cigarette smoke exposure protocol
C57BL/6, BALB/c, and CD1 mice as well as IL-13, IL-
18, IL-1R1, and BRP-39 KO mice were exposed to cigar-
e t t es m o k eu s i n gaw h o l eb o d ys m o k ee x p o s u r es y s t e m
(SIU-48, Promech Lab AB (Vintrie, Sweden)) as
described in detail previously [19]. Mice were exposed
to 12 2R4F reference cigarettes with filters removed
(Tobacco and Health Research Institute, University of
Kentucky, Lexington, KY, USA) for a period of approxi-
mately 50 minutes, twice daily, for four days. This expo-
sure period followed an initial acclimatization period
whereby mice were accustomed to smoke exposure
chamber over a three-day period. Control animals were
exposed to room air only.
HDM exposure protocol
WT C57BL/6 and BALB/c mice as well as IL-13, IL-
1R1, and BRP-39 KO mice were exposed to HDM using
a protocol that was described in detail previously [24].
Briefly, animals were anesthetized with isoflurane
(Abbott Laboratories, Saint-Laurent, Quebec, Canada)
using a rodent anesthetic machine (Penlon Limited
Abingdon, England) and inoculated intranasally with 25
μg of HDM extract (Greer Laboratories, Lenoir, NC,
USA) in 10 μl of saline, 5 days/week for two consecutive
weeks.
OVA Challenge Protocol
WT BALB/c and BRP-39 KO mice were placed into a
plexiglass chamber and exposed to 1% (w/v) OVA
(Grade V, Sigma-Aldrich, Oakville, ON, Canada) in ster-
i l es a l i n ef o r2 0m i n u t e sd a i ly as described previously
[25]. The aerosol was generated using a Bennet twin
nebulizer at a flow rate of 10 L/min. Exposure to OVA
occurred after the second of the two daily cigarette
smoke exposures. Two weeks of smoke exposure were
utilized when establishing OVA sensitization. For the
in vivo recall challenge, mice were exposed to aeroso-
lized OVA for 20 minutes on three consecutive days.
Collection of specimens
Mice were anesthetized with isoflurane and euthanized
by exsanguination prior to excision of the lungs. The
trachea was cannulated with a polyethylene tube (Becton
Dickinson, Sparks, MD). Prior to BAL, the right lobe of
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Page 2 of 12the lung was tied off and placed in ice cold PBS for gen-
erating homogenates or preparing lung single cell sus-
pensions. Bronchoalveolar lavage (BAL) fluid was
collected after instilling the left lungs with 0.25 ml of
ice cold 1x phosphate-buffered saline (1x PBS), followed
b y0 . 2m lo f1 xP B S( 6 ) .T o t a lc e l ln u m b e r sw e r e
counted using a haemocytometer. Cytospins were
stained with Hema 3 (Biochemical Sciences Inc., Swe-
desboro, New Jersey, USA). 500 cells were counted per
cytospin to identify mononuclear cells, neutrophils, and
eosinophils. Following BAL, lungs were fixed at 30 cm
H20 pressure in 10% formalin for histological
assessment.
Chitinase ELISAs
Lungs were homogenized in 1 mL PBS using a Polytron
PT 2100 homogenizer (Kinematica, Switzerland).
AMCase and BRP-39 levels were assessed by enzyme
linked immune-sorbent assay (ELISA). The assay utilized
anti-BRP-39 or anti-AMCase monoclonal antibodies for
capture and respective biotinylated polyclonal antibodies
for development (Medimmune LLC). Streptavidin conju-
gated horse radish peroxidase (HRP) (R&D Systems,
Mineapolis, MN) and tetramethylbenzidine (BioFX
Laboratories Owings Mills, MD) provided the enzymatic
reaction and 2 fold dilutions beginning at 1000 ng and
100 ng of recombinant AMCase and BRP-39 respec-
tively (Medimmune LLC), provided the standard for
quantification. To control for variability in protein con-
centration between homogenate samples, Bradford assay
(Bio Rad, Hercules, CA) was conducted to determine
the total protein of the sample. Chitinase levels were
expressed as percent of total protein.
Immunohistochemistry
Sections (4 μm) were cut from formalin-fixed, paraffin-
embedded lung tissues. Antigens were retrieved by incu-
bating tissue sections for 45 minutes in 0.01 M citrate
buffer prior to incubation for 1 hour with primary anti-
BRP-39 polyclonal rabbit antibody (Medimmune LLC)
diluted in UltrAb diluent (Thermo Fisher Scientific,
W a l t h a m ,M A )a t7μg/mL. Recombinant AMCase at a
concentration of 1 μg/mL (Medimmune LLC) was incu-
bated for 1 hr with the primary antibody to control for
cross reactivity with the similarly structured AMCase.
IHC was developed with anti-rabbit Dakocytomation
HRP (Dako, Glostrup, Denmark) and counterstained in
a modified Mayer’s Hematoxylin solution.
Flow cytometric analysis
Lung mononuclear cells were isolated as previously
described [26]. Briefly, lungs were collected in 1x phos-
phate-buffered saline (PBS) and cell suspensions were
generated by mechanical mincing and collagenase
digestion. Debris was removed by passage through
nylon mesh and cells were resuspended in 1x PBS con-
taining 0.3% bovine serum albumin (Invitrogen, Burling-
ton, ON, Canada) or in RPMI supplemented with 10%
FBS (Sigma-Aldrich, Oakville, ON, Canada), 1% L-gluta-
mine, and 1% penicillin/streptomycin for intracellular
staining (Invitrogen, Burlington, ON, Canada). 1 × 10
6
lung mononuclear cells were washed once with 1x PBS/
0.3% bovine serum albumin (BSA) and stained with pri-
mary antibodies directly conjugated to fluorochromes
for 30 minutes at 4°C. 10
5 live events were acquired
on an LSR II (BD Biosciences) flow cytometer and
data analyzed with FlowJo analysis software (TreeStar
Inc. and Standford Universit y ,P a l oA l t o ,C a l i f o r n i a ) .
The following antibodies were used for flow cytometric
analysis: FITC-conjugated anti-CD11c, PE-conjugated
anti-CD11b, PE-Alexa Flour 610-conjugated anti-CD4
(Invitrogen), PE-cy5-conjugated anti-CD19, PE-cy7-
conjugated anti-CD69, APC-conjugated anti-MHC class
II, Alexa700-conjugated anti-Gr-1 (Invitrogen), APC-
Alexa750-conjugated anti-CD8 (Invitrogen), Pacific
Blue-conjugated anti-CD3. All antibodies were pur-
chased from BD Biosciences (San Jose, California) or
eBioscience (San Diego, California) unless otherwise
indicated.
For intracellular flow cytometric analysis, whole lung
cells were cultured for 4.5 hours in the presence of
phorbol myristate acetate (PMA) and ionomycin (Sigma,
St. Louis, MO, USA). Intracellular staining for cytokines
was performed using BD cytofix/cytoperm and BD
perm/wash reagents with GolgiStop as recommended by
BD Pharmingen. Intracellular cytokine staining was per-
formed using following antibodies: FITC-conjugated
anti-T1/ST2 (MD Bioproducts), PE-conjugated anti-IL-
5, PE Cy 5-conjugated anti-CD86, PE Cy 5.5-conjugated
anti-CD11c, APC-conjugated anti-MHC II, Alexa Fluor
700-conjugated anti-Gr-1 (Invitrogen). All antibodies
were purchased from BD Biosciences (San Jose, Califor-
nia) or eBioscience (San Diego, California) unless other-
wise indicated. Isotype controls were utilized for each
stain and are demonstrated in Additional File 1.
Statistical analysis
Data are expressed as means ± SEMs. Statistical analysis
was performed with SPSS statistical software version
17.0 (Chicago, IL, USA). Univariate General Linear
Model was used to assess significance; t-tests were sub-
sequently used for 2-group comparison. Normal distri-
bution could not be assumed for neutrophil and
eosinophil data and Mann-Whitney U tests were utilized
for these comparisons. Differences were considered
statistically significant when p < 0.05. All statistically
significant findings were repeated and data shown are
representative of 2 experiments.
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Cigarette smoke-induced inflammation and expression of
chitinases and chitinase-like molecules
To investigate the impact of cigarette smoke exposure
on chitinase expression, BALB/c, C57BL/6, and CD1
mice were exposed to cigarette smoke twice daily for a
4 day period. Mice were sacrificed 18 hours after their
last smoke exposure. Figure 1A shows the BAL cellular
profile. We observed an increased total cell number in
smoke- compared to room air-exposed mice in all three
strains of mice. While all of the examined strains
demonstrated significantly increased numbers of neutro-
phils in the BAL, neutrophilia was most robust in CD1
mice and least pronounced in C57BL/6 mice.
Since chitinase expression can be induced by cigarette
smoke in humans [17], we sought to measure BRP-39
and AMCase expression in lung homogenates of room
air- and cigarette smoke-exposed BALB/c, C57BL/6, and
CD1 mice. We observed a statistically significant
increase in the chitinase-like molecule BRP-39 after
s m o k ee x p o s u r ei na l lm o u s es t r a i n s( F i g u r e1 B ) .T h e
highest baseline levels of BRP-39 and most dramatic
increase in BRP-39 levels were observed in CD1 mice.
In contrast to BRP-39, the enzymatically active AMCase
was not increased after 4 days of smoke exposure in any
of the examined mouse strains (Figure 1B). Both
AMCase and BRP-39 were significantly upregulated
after 2 weeks of HDM exposure (Figure 1C), confirming
previous reports [15,16,27,28].
Localization of BRP-39 expression after cigarette smoke
exposure
To investigate the cellular source of BRP-39 expression,
we performed immunohistochemistry on formalin fixed
lung tissues from cigarette smoke- and room air-
exposed BALB/c mice. We observed increased BRP-39
expression in the airway epithelium following smoke
exposure, although low baseline expression of BRP-39
was visible in the epithelium of room air-exposed mice
(Figure 2A). Analysis of lung parenchyma revealed posi-
tive staining in alveolar macrophages in tissues from
smoke-exposed mice (Figure 2B). The signal was BRP-
39-specific; lung tissues from 4 day smoke-exposed mice
stained with a rabbit IgG isotype control antibody and
4 day smoke-exposed BRP-39 KO mice stained with
anti-BRP39 antibodies showed no signal (Representative
pictures are shown in Figures 2A and 2B).
BRP-39 induction is IL-1 dependent after subacute
cigarette smoke exposure
Previous studies have implied that IL-13 is necessary to
induce pulmonary BRP-39 production in models of
allergic airway inflammation [15,29]. To investigate the
role of IL-13 in the cigarette smoke mediated induction
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Figure 1 Cigarette smoke and HDM induce chitinase expression in the lung. BALB/c, C57BL/6, and CD1 mice were exposed to room air
(white bar) or cigarette smoke (black bar) for four days. (A) Total cell numbers (TCN), mononuclear cells (MNC), and neutrophils (NEU) in the BAL
fluid were obtained. (B) BRP-39 and AMCase levels were assessed by ELISA. (C) BALB/c mice were challenged with saline (white bars) or HDM
(grey bars) for 2 weeks and AMCase and BRP-39 levels were assessed by ELISA in lung homogenates. n = 5, data shown are representative of
two separate experiments, * indicate P < 0.05.
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Page 4 of 12of BRP-39, IL-13 deficient and BALB/c control mice
were smoke-exposed and BRP-39 levels were deter-
mined in lung homogenates by ELISA. Figure 3A shows
that there was no difference in the cellular profile in
regards to total cells, mononuclear cells, or neutrophils
in the BAL as well as no difference in BRP-39 levels
between smoke exposed IL-13 deficient and WT mice.
IL-1R1 and IL-18 have been shown to be crucial com-
ponents in the neutrophilic inflammation elicited by
cigarette smoke [10,11,30]. We therefore investigated
w h e t h e rI L - 1 R 1a n dI L - 1 8m a yb er e s p o n s i b l ef o rB R P -
39 induction in this model. Mice deficient in IL-1R1,
and age matched C57BL/6 mice were exposed to cigar-
ette smoke. Analysis of BAL fluid revealed a significant
attenuation of cigarette smoke induced neutrophilia in
IL-1R1 KO (Figure 3B). BRP-39 expression was also
abrogated in these experiments with significantly
reduced BRP-39 induction in smoke exposed IL-1R1
KO mice. The same experiments were performed with
IL-18 deficient and age match C57BL/6 mice (Figure
3C). Smoke-exposed IL-18 KO mice showed no signifi-
cant reduction in neutrophilic inflammation when com-
pared to smoke-exposed WT mice and no impairment
in BRP-39 induction was observed. Immunohistochemis-
try showed a loss of BRP-39 signal in alveolar macro-
phages and airway epithelial cells in smoke exposed
IL-1R1 KO compared to WT mice (Figure 3D). These
data suggest that BRP-39 is induced by inflammatory
mechanisms that are integral to the neutrophil inflam-
mation elicited by cigarette smoke.
HDM induced BRP-39 expression is IL-13 and IL-1
independent
Though IL-13 is redundant to the inflammatory process
and induction of BRP-39 in a model of smoke exposure,
we sought to investigate whether IL-13 was essential for
the induction of BRP-39 in models of allergic airway
inflammation. Thus IL-13 KO and BALB/c control mice
were exposed to 2 weeks of HDM. As previously
reported in models of allergic airway inflammation [31],
IL-13 KO mice mount a dramatically decreased eosino-
philic response to HDM (Figure 4A). We observed simi-
lar expression of BRP-39 in IL-13 KO and WT control
mice, inferring a redundant role for IL-13 in the induc-
tion of BRP-39 by HDM.
To determine if IL-1 is equally a critical component of
BRP-39 induction in models of allergic airway inflamma-
tion, IL-1R1 KO mice were HDM exposed for a 2 week
period. No significant change was observed in IL-1R1 KO
mice in terms of BAL total cells, mononuclear cells, and
eosinophils when compared to WT controls (Figure 4B).
No detectable levels of BAL neutrophils were observed in
Isotype Smoke Room Air BRP-39 KO
A
B
Figure 2 BRP-39 is induced in lung epithelium and alveolar macrophages. BALB/c mice were room air or cigarette smoke-exposed for 4 days.
BRP-39 expression was visualized in lung tissues by immunohistochemistry. Images represent BRP-39-stained lung sections from room air and
cigarette smoke-exposed mice, IgG isotype stained tissue sections from smoke-exposed mice, and BRP-39 stained tissue sections from smoke-
exposed BRP-39 KO mice. Representative BRP-39 expression in (A) airway epithelium and (B) lung parenchyma are shown.
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Page 5 of 12these experiments (data not shown). Despite changes to
the inflammatory phenotype, IL-1R1 KO mice demon-
strated no change in BRP-39 expression (Figure 4B).
Therefore, BRP-39 induction by cigarette smoke is IL-1
dependent but BRP-39 induction by HDM is IL-1
independent.
BRP-39 is redundant in the inflammatory response to
cigarette smoke
Having demonstrated that BRP-39 upregulation and
neutrophil lung infiltration are IL-1 dependent phenom-
ena, we sought to determine the relevance of BRP-39 to
cigarette smoke-induced inflammation. BRP-39 KO
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1R1 KO mice. n = 5, data shown in B are representative of 2 separate experiments, * indicate P < 0.05.
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inflammation was assessed in the BAL (Figure 5A). We
observed similar total cell, mononuclear cell, and neu-
trophil counts in the BAL of WT and KO animals. Ana-
lysis of tissue neutrophils by flow cytometry revealed no
significant differences between smoke-exposed WT and
BRP-39 KO mice (Figure 5B). Previous characterization
of the smoke exposure system utilized by this study con-
firmed an increase in dendritic cells and activation of
CD4 T cells after smoke exposure [19]. Similar to tissue
neutrophils, we observed no difference in dendritic cell
numbers or CD4 T cell activation via flow cytometric
analysis (Figure 5B). To confirm the veracity of the
BRP-39 KO mice, BRP-39 expression was assessed in
these mice by ELISA and no BRP-39 was detectable in
the KO mice (data not shown). These data suggest that
BRP-39 is redundant in the inflammatory response eli-
cited by cigarette smoke.
BRP-39 is not required for cigarette smoke dependent
allergic sensitization
Studies by Lee et al showed that BRP-39 plays a crucial
role in processes leading to allergic sensitization to
OVA and HDM [15]. To reproduce these previous find-
ings, we exposed BALB/c and BRP-39 KO mice to
HDM for 2 weeks (Figure 6A). In this model, we also
observed a decrease in total cells, mononuclear cells and
e o s i n o p h i l si nt h eB A Lo fB R P - 3 9K Om i c ew h e nc o m -
pared to their WT controls. We and others have pre-
viously reported that cigarette smoke has adjuvant
properties allowing for allergic mucosal sensitization to
OVA under conditions that otherwise induce inhalation
tolerance [25,32]. To investigate whether BRP-39 is criti-
cal for cigarette smoke’s adjuvant properties, BRP-39
KO and WT control mice were concurrently exposed to
cigarette smoke and aerosolized OVA for 2 weeks. Mice
were rested for 1 month prior to 3 consecutive days of
OVA rechallenge. No differences were observed between
BRP-39 KO mice and WT controls in terms of the BAL
inflammatory profile (Figure 6B). We observed similar
numbers of mononuclear cells and eosinophils in the
BAL of BRP-39 and WT mice. Flow cytometric analysis
of lung preparations further revealed no difference in
numbers of Th2 cells (as assessed by T1/ST2 and IL-5
signal) and DC activation (as assessed by CD86+ signal
on CD11c+, MHC II+ cells) between BRP-39 KO and
WT mice (Figure 6C), suggesting that BRP-39 is not
required for allergic sensitization in the context of cigar-
ette smoke exposure.
Discussion
Though the induction of BRP-39 is observed in a wide
variety of inflammatory conditions and has been debated
as a biomarker of certain disease states, relatively little
investigation into its relevance in inflammatory
responses has been made; necessitating additional study
with in vivo models (reviewed in [33]). Thus, the objec-
tive of this study was to determine the expression and
relevance of the chitinases BRP-39 and AMCase in
cigarette smoke-induced airway inflammation and
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Figure 4 HDM induced BRP-39 is IL-13 and IL-1 independent. WT BALB/c and IL-13 KO mice were saline (white bars) or HDM (grey bars)
exposed for 10 days. (A) Data show total cell numbers (TCN), mononuclear cells (MNC), and eosinophils (EOS) in bronchoalveolar lavage fluid as
well as BRP-39 expression in lung homogenates. (B) The same readouts are shown for IL-1R1 KO mice receiving HDM exposure. n = 5-10, data
shown in B are representative of 2 separate experiments, * indicate P < 0.05.
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because of previously established chitinase expression in
allergic airways disease.
To pursue this study, we utilized a murine whole body
cigarette smoke exposure system. Mice were exposed to
cigarette smoke for 4 consecutive days. This time point
was chosen based on previous time course experiments
to determine when a robust inflammatory response
could first be reliably detected (data not shown).
Though this time point is ideal for assessing cellular
inflammation, the smoke exposure period is not long
enough to measure lung destruction characteristic of
emphysema. The inflammation induced is largely neu-
trophilic in nature, an observation similar to that
described in COPD patients [34,35]. As further valida-
tion of this model, we previously reported levels of car-
boxyhemoglobin (a measurement of the saturation of
hemoglobin with carbon monoxide) and cotinine (a
metabolic product of nicotine) similar to the human
reference [19]. Similarly, the HDM model utilized a
2w e e kt i m ep o i n ta st h i sh a sb e e np r e v i o u s l ye s t a b -
lished as the earliest time point to observe robust eosi-
nophilic inflammation [36], while prolonged exposure is
required to induce airway remodeling. Thus, the focus
of both models is the inflammatory response, which is
believed to drive, at least in part, the pathogenesis of
COPD and asthma.
The increase in BRP-39 expression after smoke expo-
sure is a robust event observed across inbred strains and
outbred stock. This induction is in agreement with clini-
cal observations of increased YKL-40 expression levels
in smokers and COPD patients. Unlike models of aller-
g i ca i r w a yi n f l a m m a t i o nw h e r eb o t hA M C a s ea n dB R P -
39 have been shown to be elevated [15,16], increased
expression levels of AMCase were not observed follow-
ing smoke exposure, thus distinguishing the chitinase
expression profile elicited by cigarette smoke from the
one elicited by allergens.
The induction of BRP-39 and the infiltration of cells
into the lungs were concurrent phenomena after 4 days
of cigarette smoke exposure. IHC on lung sections
implicated epithelial cells and macrophages as the pri-
mary producers of BRP-39 in this model, which is in
agreement with the YKL40 expression pattern in
humans and other smoke exposure models [17,18].
Others have found that neutrophils are capable of pro-
ducing YKL-40 in humans [37]; however, no evidence in
our model suggests that this prominent inflammatory
cell type is contributing to BRP-39 production. Regard-
less of the relevance of BRP-39 in disease pathology, its
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Figure 5 Cigarette smoke induced inflammation is not affected by BRP-39 deficiency. BRP-39 KO and BALB/c WT mice were room air (white
bars) or smoke (black bars) exposed for four days. (A) Data show total cell numbers (TCN), mononuclear cells (MNC), and neutrophils (NEU) in
BAL fluid. (B) Flow cytometric analysis of lung digests for the presence of neutrophils (Gr-1+), dendritic cells (CD11c+ MHCII+), and CD4 T cell
activation (CD69+). n = 5, data shown are representative of 2 separate experiments,* indicate P < 0.05.
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Page 8 of 12expression is closely associated with the inflammatory
response and BRP-39 remains a biomarker of inflamma-
tory disease.
Following the initial observation of BRP-39 induction
in allergic disease, Th2 mechanisms were postulated as
being responsible for driving this process [15,29]. Th2
responses are believed to be crucial for parasitic defense
and the induction of enzymes with the potential to
break down the protective sheaths of parasitic nema-
todes would be of great efficacy to such responses. The
finding that enzymatically active AMCase is induced in
an IL-13 dependent manner in Th2 driven inflammation
reinforced this hypothesis [16]. Though Th2 cytokines,
including IL-13, have been detected in the smoke expo-
sure model utilized in this study [19], IL-13 KO mice
revealed that BRP-39 induction by cigarette smoke is
IL-13 independent. This is not entirely surprising as IL-
13 does not appear to be a critical mediator of inflam-
mation in the smoke exposure system for its deficiency
also has no effect on cellular inflammation. Conversely,
it was rather unexpected that in HDM-induced allergic
inflammation; which is Th2-driven, IL-13 was unneces-
sary for the induction of BRP-39; in other words
BRP-39 induction was unaltered and yet eosinophilic
inflammation was markedly attenuated. These results are
at variance with previous work that implicated BRP-39 as
a crucial inflammatory component in similar HDM mod-
els [15]. This represents a significant finding and expands
on previous work by Lee et al in which IL-13 dependence
for BRP-39 induction in allergic airway inflammation was
strongly implied by experiments where transgenic
amounts of IL-13 had been over-expressed in the lungs
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Page 9 of 12[15]. The experiments by Lee et al, however, did not uti-
lize an IL-13 KO strain and as such these data only
demonstrate that IL-13 is able to induce BRP-39 and not
whether IL-13 is essential for BRP-39 induction. Our
data show that although IL-13 is capable of inducing
BRP-39 expression, it is redundant in models of cigarette
smoke- and allergen-induced airway inflammation in the
induction of BRP-39.
IL-1 has been implicated in vitro in BRP-39 induction
[38]. The IL-1R1 KO mice were chosen for this reason
and because IL-1R1 deficiency was sufficient to attenu-
ate smoke-induced neutrophilic inflammation. The
observation that smoke-exposed IL-1R1 KO mice did
not up-regulate expression of BRP-39 suggests a crucial
role of IL-1 in this phenomenon. This provides further
evidence that the induction of BRP-39 is closely tied to
inflammatory pathways. Further investigation of the
importance of IL-1 in the induction of BRP-39 in aller-
gic inflammation revealed that IL-1R1 was not crucial in
the HDM model, highlighting the different inflammatory
pathways engaged by these two models. Our data which
confirms the importance of BRP-39 in HDM-induced
inflammation imply that BRP-39, in the context of
allergy, is part of an immune inflammatory pathway cru-
cial to mononuclear cell and eosinophil recruitment that
is not dependent on IL-1 or IL-13.
Recently Matsuura et al have implicated IL-18 as a
mechanistic component of BRP-39 induction in a mur-
i n em o d e lo fs m o k ee x p o s u r e[ 1 8 ] .T h e s ed a t ac o m p l e -
ment previous experiments that implicate IL-18 as a
crucial component of cigarette smoke-induced inflam-
mation [10]. Our data generated in IL-18 KO mice sug-
gest that IL-18 is redundant in the inflammatory
response and in the induction of BRP-39 which was
confirmed by experiments with IL-18 receptor KO mice
(data not shown). This discrepancy could be the result
of different smoke exposure conditions as Matsuura
et al u t i l i z e dan o s eo n l ys m o k ee x p o s u r ea p p a r a t u s
characterized by Shapiro et al [39], as opposed to a
whole body smoke exposure system. A more likely
explanation of the discrepancy is the length of smoke-
exposure, as our study exposed mice to smoke for four
days while Matsuura et al exposed mice to smoke for a
month to determine the mechanistic relevance of IL-18.
The four day time point was chosen for this study
because experiments showed a greater induction of
BRP-39 at subacute time points when compared to the
chronic setting (data not shown). These findings taken
in context with the data from IL-1R1 KO mice imply a
timeline for cigarette smoke induced inflammation
where IL-1 inflammatory pathways are more important
early on in disease progression with IL-18 mediated
pathways engaged after sustain cigarette smoke stimuli.
Evidence such as the stimulation of cells with YKL-40
inducing inflammatory chemokines has implied a role
for this YKL-40 and BRP-39 in cellular inflammation
[17,38], yet BRP-39 deficiency did not lead to signifi-
cantly attenuated lung-infiltrating cell types after smoke
exposure. The redundant nature of BRP-39 in this
inflammatory response represents the most striking
finding of this study and again contrasts the work by
Matsuura et al [18]. As stated before, this is likely the
result of the different durations of smoke exposure as
Matsuura et al did not witness reduced inflammation in
smoke-exposed BRP-39 KO mice until at least 3 months
of smoke-exposure. This implicates BRP-39 in the survi-
val of inflammatory cells in a chronic inflammatory set-
ting and not in the initial recruitment of cells to the
lungs. The lack of significant difference in tissue neutro-
phils, DCs, and CD4 T cell activation more specifically
reinforces the redundant nature of BRP-39 in the early
stages of cigarette smoke-induced inflammation.
Another striking conclusion of these experiments was
that although BRP-39 has been shown to be crucial for
allergic sensitization, it is redundant in the adjuvant
properties of cigarette smoke. This implies a different
mechanism of sensitization when cigarette smoke is uti-
lized as an adjuvant. This is not an unprecedented asser-
tion as HDM models of allergic sensitization and models
of cigarette smoke induced OVA sensitization have been
shown to utilize different inflammatory pathways [40].
Lee et al postulated that the attenuation of allergic
responses in BRP-39 deficient mice was due to an
increase in apoptosis of a key mediating cell type [15].
Apoptosis was not assessed in this study but if there
was increased apoptosis in BRP-39 deficient animals it
was not sufficient to impede sensitization or decrease
the amount of activated DCs, implying that an increase
in apoptosis may not be sufficient to interrupt sensitiza-
tion when alternate pathways are driving sensitization.
This is likely the case when cigarette smoke is utilized
as an adjuvant.
Conclusions
In conclusion, these results demonstrate that BRP-39 is
a biomarker of cigarette smoke- and allergen-induced
inflammation. Its induction by cigarette smoke is IL-1R1
dependent, which is unique from BRP-39 induction in
HDM-induced allergic inflammation which is both IL-
1R1 and IL-13 independent. Despite the fact that BRP-
39 is induced by an inflammatory agent, BRP-39 is itself
redundant in cigarette smoke-induced inflammation.
Also, despite being a crucial mediator of allergic sensiti-
zation in widely utilized models of airway inflammation,
BRP-39 is not crucial for the adjuvant properties of
cigarette smoke. This study highlights the inflammatory
Nikota et al. Respiratory Research 2011, 12:39
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Page 10 of 12mechanism elicited by cigarette smoke to induce BRP-
39 expression which is unique from allergic inflamma-
tion as well as the function of BRP-39 in subacute
smoke exposure and cigarette smoke induced allergic
sensitization.
Additional material
Additional File 1: Isotype controls for flow cytometry data. The
appropriate isotype controls are shown in flow cytometry pseudo-dot
plots of data generated from for the lung digests of 4 day smoke
exposed lungs (A,C,D) and smoke- and OVA-exposed mice after 1 month
of cessation and 3 days of rechallenge with OVA (B,E). Histogram data (C-
E) contrasts positive stain (black line) with the appropriate isotype control
(solid grey line).
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